Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Interpersonal Relationships and Suicidal Ideation in Youth with Bipolar Disorder.

Sewall CJR, Goldstein TR, Salk RH, Merranko J, Gill MK, Strober M, Keller MB, Hafeman D, Ryan ND, Yen S, Hower H, Liao F, Birmaher B.

Arch Suicide Res. 2019 Jun 4:1-25. doi: 10.1080/13811118.2019.1616018. [Epub ahead of print]

PMID:
31159677
2.

Excessive Opioid Prescribing After Major Urologic Procedures.

Theisen KM, Myrga JM, Hale N, Cochran G, Sewall C, Macleod LC, Jacobs BL, Davies BJ.

Urology. 2019 Jan;123:101-107. doi: 10.1016/j.urology.2018.06.057. Epub 2018 Aug 24.

PMID:
30149041
3.

Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.

Biftu T, Sinha-Roy R, Chen P, Qian X, Feng D, Kuethe JT, Scapin G, Gao YD, Yan Y, Krueger D, Bak A, Eiermann G, He J, Cox J, Hicks J, Lyons K, He H, Salituro G, Tong S, Patel S, Doss G, Petrov A, Wu J, Xu SS, Sewall C, Zhang X, Zhang B, Thornberry NA, Weber AE.

J Med Chem. 2014 Apr 24;57(8):3205-12. doi: 10.1021/jm401992e. Epub 2014 Apr 2.

PMID:
24660890
4.

Exposure data for cosmetic products: lipstick, body lotion, and face cream.

Loretz LJ, Api AM, Barraj LM, Burdick J, Dressler WE, Gettings SD, Han Hsu H, Pan YH, Re TA, Renskers KJ, Rothenstein A, Scrafford CG, Sewall C.

Food Chem Toxicol. 2005 Feb;43(2):279-91.

PMID:
15621341
5.

Synthesis and properties of an EGF-like domain (residues 361-406) in the extreme N-terminal region of the mouse EGF precursor.

Diaugustine RP, Henry R, Sewall CH, Suarez-Quian CA, Walker MP.

Growth Factors. 1999;17(1):37-48.

PMID:
10495961
6.

Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12626-30.

7.

Differences in binding of epidermal growth factor to liver membranes of TCDD-resistant and TCDD-sensitive rats after a single dose of TCDD.

Tuomisto J, Sewall CH, Unkila M, Pohjanvirta R, Clark GC, Viluksela M, Rozman K, Lucier GW.

Environ Toxicol Pharmacol. 1996 Apr 15;1(2):109-16.

PMID:
21781670
8.

A mechanistic model of effects of dioxin on thyroid hormones in the rat.

Kohn MC, Sewall CH, Lucier GW, Portier CJ.

Toxicol Appl Pharmacol. 1996 Jan;136(1):29-48.

PMID:
8560478
9.

Receptor-mediated events and the evaluation of the Environmental Protection Agency (EPA) of dioxin risks.

Sewall CH, Lucier GW.

Mutat Res. 1995 Dec;333(1-2):111-22. Review. No abstract available.

PMID:
8538618
10.

Induced gene transcription: implications for biomarkers.

Sewall CH, Bell DA, Clark GC, Tritscher AM, Tully DB, Vanden Heuvel J, Lucier GW.

Clin Chem. 1995 Dec;41(12 Pt 2):1829-34. Review.

11.
12.

TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation.

Sewall CH, Clark GC, Lucier GW.

Toxicol Appl Pharmacol. 1995 Jun;132(2):263-72.

PMID:
7785053
13.

Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Sewall CH, Flagler N, Vanden Heuvel JP, Clark GC, Tritscher AM, Maronpot RM, Lucier GW.

Toxicol Appl Pharmacol. 1995 Jun;132(2):237-44.

PMID:
7540335
14.

Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol.

Yager JD, Zurlo J, Sewall CH, Lucier GW, He H.

Carcinogenesis. 1994 Oct;15(10):2117-23.

PMID:
7955042
15.

Dose-response and risk assessment considerations for receptor-mediated effects: case study with a TCDD hepatic tumor promotion model.

Sewall CH, Lucier GW.

Prog Clin Biol Res. 1994;387:155-71. Review. No abstract available.

PMID:
7972245
16.

TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD.

Sewall CH, Lucier GW, Tritscher AM, Clark GC.

Carcinogenesis. 1993 Sep;14(9):1885-93.

PMID:
8403215
17.

Carcinogenicity of TCDD in laboratory animals: implications for risk assessment.

Lucier G, Clark G, Hiermath C, Tritscher A, Sewall C, Huff J.

Toxicol Ind Health. 1993 Jul-Aug;9(4):631-68. Review. No abstract available. Erratum in: Toxicol Ind Health 1994 May-Jun;10(3):247.

PMID:
8296316
18.

A mechanistic model of effects of dioxin on gene expression in the rat liver.

Kohn MC, Lucier GW, Clark GC, Sewall C, Tritscher AM, Portier CJ.

Toxicol Appl Pharmacol. 1993 May;120(1):138-54.

PMID:
8511776
19.

Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment.

Portier C, Tritscher A, Kohn M, Sewall C, Clark G, Edler L, Hoel D, Lucier G.

Fundam Appl Toxicol. 1993 Jan;20(1):48-56.

PMID:
8381755
20.

Meprane in the treatment of the menopausal syndrome; an evaluation of estrogenic efficiency and toxicity.

COULTON D, SEWALL CW.

Am J Obstet Gynecol. 1948 Sep;56(3):541-8. No abstract available.

PMID:
18877188
21.

Manual removal of the placenta; a benign procedure.

SEWALL CW, COULTON D.

Am J Obstet Gynecol. 1946 Oct;52(4):564-73. No abstract available.

PMID:
21001392

Supplemental Content

Loading ...
Support Center